Directed differentiation of pluripotent stem cells to kidney cells

Seminars in Nephrology

Volumn 34, Issue 4, 2014, Pages 445-461

  Lam, Albert Q ^a,b   Freedman, Benjamin S ^a   Bonventre, Joseph V ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Embryonic stem cell; IPS cell; Kidney cell differentiation; Kidney development; Kidney on a chip; Pluripotent stem cell

Indexed keywords

AQUAPORIN 1; CD24 ANTIGEN; MEMBRANE PROTEIN; PROTEIN EYA1; PROTEIN LHX1; PROTEIN OSR1; RENIN; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG; WT1 PROTEIN;

BIOENGINEERING; BRANCHING MORPHOGENESIS; CELL AGGREGATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL REGENERATION; CHRONIC KIDNEY DISEASE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY TRANSPLANTATION; MESODERM; NEPHRON; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CYTOLOGY; EMBRYONIC STEM CELL; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; KIDNEY; MOUSE; PHYSIOLOGY; TISSUE ENGINEERING;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; IN VITRO TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; KIDNEY; MICE; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84907980439     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2014.06.011     Document Type: Review

References (96)

1. Greenberg A., Cheung A.K. Primer on kidney diseases 2009, Saunders/Elsevier, Philadelphia, PA. 5th ed.
2. Hartman H.A., Lai H.L., Patterson L.T. Cessation of renal morphogenesis in mice. Dev Biol 2007, 310:379-387.
3. Little M.H., McMahon A.P. Mammalian kidney development: principles, progress, and projections. Cold Spring Harbor Perspect Biol 2012, 4:1-18.
4. Faa G., Gerosa C., Fanni D., et al. Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. J Matern Fetal Neonatal Med 2010, 23(Suppl 3):129-133.
5. Humphreys B.D., Valerius M.T., Kobayashi A., et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008, 2:284-291.
6. Witzgall R., Brown D., Schwarz C., Bonventre J.V. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994, 93:2175-2188.
7. Gilbert S.F. Developmental biology 2010, Sinauer Associates, Sunderland, MA. 9th ed.
8. Grobstein C. Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. Science 1953, 118:52-55.
9. Carroll T.J., McMahon A.P. Secreted molecules in metanephric induction. J Am Soc Nephrol 2000, 11(Suppl 16):S116-S119.
10. Rogers S.A., Hammerman M.R. Prolongation of life in anephric rats following de novo renal organogenesis. Organogenesis 2004, 1:22-25.
11. Dekel B., Reisner Y. Engraftment of human early kidney precursors. Transplant Immunol 2004, 12:241-247.
12. Harari-Steinberg O., Metsuyanim S., Omer D., et al. Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol Med 2013, 5:1556-1568.
13. Hammerman M.R. Growing new kidneys in situ. Clin Exp Nephrol 2004, 8:169-177.
14. Saxen L., Lehtonen E., Karkinen-Jaaskelainen M., Nordling S., Wartiovaara J. Are morphogenetic tissue interactions mediated by transmissible signal substances or through cell contacts?. Nature 1976, 259:662-663.
15. Gilbert SF. Developmental biology. 10th ed. Sunderland, MA: Sinauer Associates, Inc.
16. Barak H., Huh S.H., Chen S., et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev Cell 2012, 22:1191-1207.
17. Boland M.J., Hazen J.L., Nazor K.L., et al. Adult mice generated from induced pluripotent stem cells. Nature 2009, 461:91-94.
18. Zhao X.Y., Li W., Lv Z., et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009, 461:86-90.
19. Cahan P., Daley G.Q. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 2013, 14:357-368.
20. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
21. Grskovic M., Javaherian A., Strulovici B., Daley G.Q. Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011, 10:915-929.
22. Wernig M., Meissner A., Foreman R., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
23. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
24. Kaneko S., Yamanaka S. To be immunogenic, or not to be: that's the iPSC question. Cell Stem Cell 2013, 12:385-386.
25. Lensch M.W., Mummery C.L. From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel prize. Stem Cell Rep 2013, 1:5-17.
26. Freedman B.S., Lam A.Q., Sundsbak J.L., et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 2013, 24:1571-1586.
27. Lam A.Q., Freedman B.S., Morizane R., Lerou P.H., Valerius M.T., Bonventre J.V. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 2014, 25:1211-1225.
28. Mae S., Shono A., Shiota F., et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun 2013, 4:1367.
29. Xia Y., Nivet E., Sancho-Martinez I., et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol 2013, 15:1507-1515.
30. Takasato M., Er P.X., Becroft M., et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 2014, 16:118-126.
31. Taguchi A., Kaku Y., Ohmori T., et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 2014, 14:53-67.
32. Cohen D.E., Melton D. Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet 2011, 12:243-252.
33. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
34. Lin S.A., Kolle G., Grimmond S.M., et al. Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev 2010, 19:1637-1648.
35. Chen K.G., Mallon B.S., McKay R.D., Robey P.G. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell 2014, 14:13-26.
36. Yamamoto M., Cui L., Johkura K., et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol 2006, 290:F52-F60.
37. Steenhard B.M., Isom K.S., Cazcarro P., et al. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol 2005, 16:1623-1631.
38. Osafune K., Nishinakamura R., Komazaki S., Asashima M. In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ 2002, 44:161-167.
39. Wiles M.V., Johansson B.M. Embryonic stem cell development in a chemically defined medium. Exp Cell Res 1999, 247:241-248.
40. Johansson B.M., Wiles M.V. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995, 15:141-151.
41. Kim D., Dressler G.R. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005, 16:3527-3534.
42. Kobayashi T., Tanaka H., Kuwana H., et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun 2005, 336:585-595.
43. Bruce S.J., Rea R.W., Steptoe A.L., Busslinger M., Bertram J.F., Perkins A.C. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation 2007, 75:337-349.
44. Vigneau C., Polgar K., Striker G., et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol 2007, 18:1709-1720.
45. Morizane R., Monkawa T., Itoh H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun 2009, 390:1334-1339.
46. Ren X., Zhang J., Gong X., et al. Differentiation of murine embryonic stem cells toward renal lineages by conditioned medium from ureteric bud cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2010, 42:464-471.
47. Nishikawa M., Yanagawa N., Kojima N., et al. Stepwise renal lineage differentiation of mouse embryonic stem cells tracing in vivo development. Biochem Biophys Res Commun 2012, 417:897-902.
48. Morizane R., Monkawa T., Fujii S., et al. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular structures in vitro and differentiate into renal tubular cells. PLoS One 2013, 8:e64843.
49. Mae S., Shirasawa S., Yoshie S., et al. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem Biophys Res Commun 2010, 393:877-882.
50. Nakane A., Kojima Y., Hayashi Y., Kohri K., Masui S., Nishinakamura R. Pax2 overexpression in embryoid bodies induces upregulation of integrin alpha8 and aquaporin-1. In Vitro Cell Dev Biol Anim 2009, 45:62-68.
51. Hanna J., Cheng A.W., Saha K., et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 2010, 107:9222-9227.
52. Singh A.M., Bechard M., Smith K., Dalton S. Reconciling the different roles of Gsk3beta in "naive" and "primed" pluripotent stem cells. Cell Cycle 2012, 11:2991-2996.
53. Wray J., Kalkan T., Smith A.G. The ground state of pluripotency. Biochem Soc Trans 2010, 38:1027-1032.
54. Rossant J. Stem cells and early lineage development. Cell 2008, 132:527-531.
55. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2000, 97:11307-11312.
56. Batchelder C.A., Lee C.C., Matsell D.G., Yoder M.C., Tarantal A.F. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation 2009, 78:45-56.
57. Song B., Smink A.M., Jones C.V., et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One 2012, 7:e46453.
58. Saleem M.A., O'Hare M.J., Reiser J., et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002, 13:630-638.
59. Narayanan K., Schumacher K.M., Tasnim F., et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int 2013, 83:593-603.
60. Mugford J.W., Sipila P., McMahon J.A., McMahon A.P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008, 324:88-98.
61. Kobayashi A., Valerius M.T., Mugford J.W., et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008, 3:169-181.
62. Dressler G.R. Advances in early kidney specification, development and patterning. Development 2009, 136:3863-3874.
63. Araoka T., Mae S., Kurose Y., et al. Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS One 2014, 9:e84881.
64. Wilson P.D. Mouse models of polycystic kidney disease. Curr Top Dev Biol 2008, 84:311-350.
65. Novarino G., Akizu N., Gleeson J.G. Modeling human disease in humans: the ciliopathies. Cell 2011, 147:70-79.
66. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
67. Humphreys B.D., Lin S.L., Kobayashi A., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010, 176:85-97.
68. Zhou T., Benda C., Duzinger S., et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011, 22:1221-1228.
69. Aasen T., Izpisua Belmonte J.C. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 2010, 5:371-382.
70. Thatava T., Armstrong A.S., De Lamo J.G., et al. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther 2011, 2:48.
71. Frumkin T., Malcov M., Telias M., et al. Human embryonic stem cells carrying mutations for severe genetic disorders. In Vitro Cell Dev Biol Anim 2010, 46:327-336.
72. Chen Y., Luo R., Xu Y., et al. Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine. Rheumatol Int 2013, 33:2127-2134.
73. Tropel P., Tournois J., Come J., et al. High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis. In Vitro Cell Dev Biol Anim 2010, 46:376-385.
74. Kiprilov E.N., Awan A., Desprat R., et al. Human embryonic stem cells in culture possess primary cilia with hedgehog signaling machinery. J Cell Biol 2008, 180:897-904.
75. Nauli S.M., Rossetti S., Kolb R.J., et al. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J Am Soc Nephrol 2006, 17:1015-1025.
76. Xu C., Rossetti S., Jiang L., et al. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am J Physiol Renal Physiol 2007, 292:F930-F945.
77. Geng L., Okuhara D., Yu Z., et al. Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif. J Cell Sci 2006, 119:1383-1395.
78. Hofherr A., Kottgen M. Induced pluripotent stem cells from polycystic kidney disease patients: a novel tool to model the pathogenesis of cystic kidney disease. J Am Soc Nephrol 2013, 24:1507-1509.
79. Boulting G.L., Kiskinis E., Croft G.F., et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011, 29:279-286.
80. Kim K., Doi A., Wen B., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
81. Song B., Niclis J.C., Alikhan M.A., et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011, 22:1213-1220.
82. Montserrat N., Ramirez-Bajo M.J., Xia Y., et al. Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2. J Biol Chem 2012, 287:24131-24138.
83. Ding Q., Lee Y.K., Schaefer E.A., et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 2013, 12:238-251.
84. Mali P., Yang L., Esvelt K.M., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
85. Davies J.A., Unbekandt M., Ineson J., Lusis M., Little M.H. Dissociation of embryonic kidney followed by re-aggregation as a method for chimeric analysis. Methods Mol Biol 2012, 886:135-146.
86. Hendry C.E., Vanslambrouck J.M., Ineson J., et al. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J Am Soc Nephrol 2013, 24:1424-1434.
87. Yokoo T., Ohashi T., Shen J.S., et al. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A 2005, 102:3296-3300.
88. Kobayashi T., Yamaguchi T., Hamanaka S., et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 2010, 142:787-799.
89. Usui J., Kobayashi T., Yamaguchi T., Knisely A.S., Nishinakamura R., Nakauchi H. Generation of kidney from pluripotent stem cells via blastocyst complementation. Am J Pathol 2012, 180:2417-2426.
90. Davies J. Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testing. Drug Discov Today 2014, 19:725-729.
91. Lesher-Perez S.C., Frampton J.P., Takayama S. Microfluidic systems: a new toolbox for pluripotent stem cells. Biotechnol J 2013, 8:180-191.
92. Nikkhah M., Edalat F., Manoucheri S., Khademhosseini A. Engineering microscale topographies to control the cell-substrate interface. Biomaterials 2012, 33:5230-5246.
93. Dado D., Sagi M., Levenberg S., Zemel A. Mechanical control of stem cell differentiation. Regen Med 2012, 7:101-116.
94. Keung A.J., Kumar S., Schaffer D.V. Presentation counts: microenvironmental regulation of stem cells by biophysical and material cues. Ann Rev Cell Dev Biol 2010, 26:533-556.
95. Guilak F., Cohen D.M., Estes B.T., Gimble J.M., Liedtke W., Chen C.S. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009, 5:17-26.
96. Ben-David U., Gan Q.F., Golan-Lev T., et al. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 2013, 12:167-179.